Targeting the ERK pathway for the treatment of Cushing's disease.

about

Inhibition of HSP90 sensitizes a novel Raf/ERK dual inhibitor CY-9d in triple-negative breast cancer cells.Recent advances in understanding corticotroph pituitary tumor initiation and progression

P2860

Q47122504-8ACB8D10-A2BD-4C1D-A408-9C0B28FF0BE4 Q58694608-7BA18615-1F75-4CEE-853B-83ED7F3907F4

P2860

Targeting the ERK pathway for the treatment of Cushing's disease.

Item

http://www.wikidata.org/entity/Q42317496

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeting the ERK pathway for the treatment of Cushing's disease.

@en

Targeting the ERK pathway for the treatment of Cushing's disease.

@nl

type

Item

label

Targeting the ERK pathway for the treatment of Cushing's disease.

@en

Targeting the ERK pathway for the treatment of Cushing's disease.

@nl

prefLabel

Targeting the ERK pathway for the treatment of Cushing's disease.

@en

Targeting the ERK pathway for the treatment of Cushing's disease.

@nl

P1476

Targeting the ERK pathway for the treatment of Cushing's disease.

@en

P2093

Anthony P Heaney

http://www.w3.org/2001/XMLSchema#string

Dongyun Zhang

http://www.w3.org/2001/XMLSchema#string

Marilene B Wang

http://www.w3.org/2001/XMLSchema#string

Marvin Bergsneider

http://www.w3.org/2001/XMLSchema#string

P2860

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.

Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4

Medical treatment of Cushing's disease: Overview and recent findings.

MEK and the inhibitors: from bench to bedside.

Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily.

What is the cause of Cushing's disease?

The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.

Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease

Management of recurrent Cushing's disease.

Molecular markers in pituitary tumors.

P304

69149-69158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12381

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27708250

http://www.w3.org/2001/XMLSchema#string

P932

5342466

http://www.w3.org/2001/XMLSchema#string

Targeting the ERK pathway for the treatment of Cushing's disease.

about

P2860

P2860

Targeting the ERK pathway for the treatment of Cushing's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932